Northrop Grumman (NOC) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Q2 2024 sales rose 7% year-over-year to $10.2 billion, with growth across all four segments, led by Aeronautics Systems at 14%.
Net earnings for Q2 2024 increased 16% to $940 million, and diluted EPS rose 19% to $6.36, driven by higher operating income and a lower share count.
Free cash flow surged 80% to $1.1 billion, supported by improved working capital and lower tax payments.
Backlog reached $83.1 billion, with a Q2 book-to-bill ratio of 1.5x and net awards of $15.1 billion.
The company increased 2024 revenue and EPS guidance, with 85% of sales from advanced technology and 15% from strategic deterrent programs.
Financial highlights
Q2 operating income increased 13% year-over-year to $1.09 billion; operating margin improved to 10.7%.
Q2 segment operating income was $1.1 billion, up 5% year-over-year.
Free cash flow for Q2 was $1.1 billion, up 80% year-over-year; cash and cash equivalents totaled $3.3 billion at quarter-end.
Dividend increased by 10% in May, marking 21 consecutive annual increases.
Weighted average diluted shares outstanding decreased 3% year-over-year to the mid-147 million range.
Outlook and guidance
2024 sales guidance raised to $41.0–$41.4 billion; MTM-adjusted EPS guidance increased to $24.90–$25.30.
Segment guidance updated to reflect realignment of Strategic Deterrent Systems from Space to Defense Systems.
Free cash flow CAGR projected above 15% through 2026; capital expenditures targeted at $1.8 billion for 2024.
Margins expected to improve from 11% in 2024, with a path to 12% over the decade.
Guidance reflects expectations amid inflation, labor, supply chain, and geopolitical risks; does not assume government shutdown or spending cuts.
Latest events from Northrop Grumman
- Accelerating defense demand fuels growth, investment, and innovation across all business segments.NOC
Citi's Global Industrial Tech & Mobility Conference 202618 Feb 2026 - Board re-elected, dividends raised, and shareholder clawback proposal rejected.NOC
AGM 20253 Feb 2026 - Record backlog, strong sales, and robust cash flow drive positive 2026 outlook.NOC
Q4 20252 Feb 2026 - Growth, margin expansion, and international demand drive a resilient, diversified portfolio.NOC
Morgan Stanley‘s 12th Annual Laguna Conference 202420 Jan 2026 - Q3 sales up 2%, EPS up 13%, and 2024 guidance raised on record backlog and margin gains.NOC
Q3 202418 Jan 2026 - Record backlog, global demand, and digital innovation drive growth and margin expansion.NOC
Baird 2024 Global Industrials Conference14 Jan 2026 - Record backlog, strong sales, and margin expansion drive robust 2025 outlook.NOC
Q4 20249 Jan 2026 - International demand, digital innovation, and efficiency drive strong growth and future optimism.NOC
Citi’s 2025 Global Industrial Tech and Mobility Conference8 Jan 2026 - Q1 2025 sales and earnings fell on B-21 charges, but backlog and guidance remain strong.NOC
Q1 202520 Dec 2025